206 related articles for article (PubMed ID: 9414590)
1. [Polarizing microscopy of crystalline drugs based on the crystal habit determination for the purpose of a rapid estimation of crystal habits, particle sizes and specific surface areas of small crystals].
Watanabe A
Yakugaku Zasshi; 1997 Nov; 117(10-11):771-85. PubMed ID: 9414590
[TBL] [Abstract][Full Text] [Related]
2. [Study of crystalline drugs by means of a polarizing microscope. XI. Analysis of the particle size distribution of a principle agent in a trituration of phenytoin].
Watanabe A; Ohnuma N
Yakugaku Zasshi; 1990 Jul; 110(7):516-21. PubMed ID: 2231311
[TBL] [Abstract][Full Text] [Related]
3. [A trial production of a table of the optical crystallographic characteristics of crystalline drugs including crystal habits (study of crystalline drugs by means of a polarizing microscope. XIX].
Watanabe A
Yakugaku Zasshi; 2002 Aug; 122(8):595-606. PubMed ID: 12187776
[TBL] [Abstract][Full Text] [Related]
4. [Crystal morphological and habit investigations of crystalline drugs. III. Sulfamethizole, levodopa and phenobarbital].
Watanabe A; Ohnuma N
Yakugaku Zasshi; 1994 Feb; 114(2):80-8. PubMed ID: 8169772
[TBL] [Abstract][Full Text] [Related]
5. [Crystallographic characteristics of crystal habits and their peculiarity to the substance (study of crystalline drugs by mesns of a polarizing microscope. XVIII)].
Watanabe A; Ohnuma N
Yakugaku Zasshi; 2000 Mar; 120(3):290-7. PubMed ID: 10723271
[TBL] [Abstract][Full Text] [Related]
6. [Crystal morphological and habit investigations of crystalline drugs. I. Phenytoin].
Watanabe A; Ohnuma N
Yakugaku Zasshi; 1992 Jun; 112(6):401-8. PubMed ID: 1432592
[TBL] [Abstract][Full Text] [Related]
7. [Crystal morphological and habit investigations of crystalline drugs. II. Amobarbital, barbital and ephedrine hydrochloride].
Watanabe A; Ohnuma N
Yakugaku Zasshi; 1993 Feb; 113(2):159-66. PubMed ID: 8487158
[TBL] [Abstract][Full Text] [Related]
8. [Study of crystalline drugs by means of polarizing microscope. VII. Polarizing microscopy of crystalline drugs listed in the Japanese Pharmacopoeia X (3)].
Watanabe A; Yamaoka Y; Kuroda K; Yokoyama T; Umeda T
Yakugaku Zasshi; 1985 May; 105(5):481-90. PubMed ID: 4032238
[No Abstract] [Full Text] [Related]
9. Study of crystalline drugs by means of polarizing microscope. III. Key refractive indices of some crystalline drugs and their measurement using an improved immersion method.
Watanabe A; Yamaoka Y; Kuroda K
Chem Pharm Bull (Tokyo); 1980 Feb; 28(2):372-8. PubMed ID: 7389012
[No Abstract] [Full Text] [Related]
10. [Study of crystalline drugs by means of polarizing microscope. IX. Preparation of the charts for simultaneous analysis, identification and measurement of thickness of crystalline drugs listed in the Japanese Pharmacopoeia X].
Watanabe A
Yakugaku Zasshi; 1986 Sep; 106(9):825-36. PubMed ID: 3795005
[No Abstract] [Full Text] [Related]
11. Crystal face identification by Raman microscopy for assessment of crystal habit of a drug.
Moriyama K; Furuno N; Yamakawa N
Int J Pharm; 2015 Mar; 480(1-2):101-6. PubMed ID: 25615983
[TBL] [Abstract][Full Text] [Related]
12. Interferometric method for birefringence determination with a polarizing microscope.
Dumitraşcu L; Dumitraşcu I; Dorohoi DO; Toma M
Opt Express; 2008 Dec; 16(25):20884-90. PubMed ID: 19065227
[TBL] [Abstract][Full Text] [Related]
13. Crystal Habits of Itraconazole Microcrystals: Unusual Isomorphic Intergrowths Induced via Tuning Recrystallization Conditions.
Mugheirbi NA; Tajber L
Mol Pharm; 2015 Sep; 12(9):3468-78. PubMed ID: 26275018
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic droplet liquid reactors for active pharmaceutical ingredient crystallization by diffusion controlled solvent extraction.
Tona RM; McDonald TAO; Akhavein N; Larkin JD; Lai D
Lab Chip; 2019 Jun; 19(12):2127-2137. PubMed ID: 31114833
[TBL] [Abstract][Full Text] [Related]
15. Study of crystalline drugs by means of a polarizing microscope. VIII. A simple and rapid method to measure the thickness of a crystalline drug and its application to the quality testing of poorly soluble drugs.
Watanabe A
Chem Pharm Bull (Tokyo); 1986 Jun; 34(6):2599-605. PubMed ID: 3769075
[No Abstract] [Full Text] [Related]
16. Analysis of edge birefringence.
Oldenbourg R
Biophys J; 1991 Sep; 60(3):629-41. PubMed ID: 1932552
[TBL] [Abstract][Full Text] [Related]
17. Effect of crystal habit on the dissolution behaviour of simvastatin crystals and its relationship to crystallization solvent properties.
Bukovec P; Benkic P; Smrkolj M; Vrecer F
Pharmazie; 2016 May; 71(5):263-8. PubMed ID: 27348970
[TBL] [Abstract][Full Text] [Related]
18. Influence of crystal habit on the surface free energy and interparticulate bonding of L-lysine monohydrochloride dihydrate.
Bandyopadhyay R; Grant DJ
Pharm Dev Technol; 2000; 5(1):27-37. PubMed ID: 10669915
[TBL] [Abstract][Full Text] [Related]
19. Optical characterization of a low solubility organic compound.
Huber HE
J Pharm Sci; 1981 Oct; 70(10):1152-4. PubMed ID: 7299651
[TBL] [Abstract][Full Text] [Related]
20. Study of crystalline drugs by means of a polarizing microscope. VI. Polarizing microscopy of drugs acting on the nervous system and on individual organs listed in the Japanese Pharmacopoeia X.
Watanabe A; Yamaoka Y; Akaho E; Kuroda K; Yokoyama T; Umeda T
Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1599-608. PubMed ID: 4042236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
